Outcome Predictors and Safety of Home Dobutamine Intravenous Infusion in End Stage Heart Failure Patients

• Published in: Journal of clinical medicine Vol. 10; no. 12; p. 2571
• Main Authors: Jobbé-Duval, Antoine, Bochaton, Thomas, Baudry, Guillaume, Bonnefoy-Cudraz, Eric, Hugon-Vallet, Elisabeth, Pozzi, Matteo, Obadia, Jean-Francois, Tomasevic, Danka, Amaz, Camille, Mewton, Nathan, Sebbag, Laurent
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 10.06.2021; MDPI
• Subjects: Clinical medicine; Clinical outcomes; Critical care; Electronic health records; end-stage heart failure; Heart failure; Heart surgery; Heart transplants; home dobutamine; Hospitalization; Hospitals; Life Sciences; Medical records; Mortality; Patients; safety; SANOFI-GENZYME; mortality; end-stage heart failure; BOEHRINGER-INGELHEIM; safety; home dobutamine

Patients in end-stage heart failure can experiment cardiogenic shock and may not be weanable from dobutamine. The fate of these patients is a challenge for doctors, patients, family, and the institution. Dobutamine use at home can be a solution. The aim of the present study was to assess the outcome...